The translation of the heading is: "Siemens plans strategic share sales to finance mega-acquisition.

Siemens is considering strategic share sales in its holdings to finance the acquisition of the company Altair, valued at $10.6 billion. These potential sales involve significant stakes in Siemens Healthineers, Siemens Energy, and Fluence, as announced by CFO Ralf Thomas on Thursday. Currently, Siemens holds 75 percent of the medical device manufacturer Siemens Healthineers, 17 percent of Siemens Energy, and 31 percent of the energy storage company Fluence. This strategic reallocation aims to free up substantial financial resources to support the company's ambitious acquisition strategy. Thomas explained to analysts that the divestment of shares in publicly listed companies is an essential component of the financing for the Altair project. These steps underscore Siemens' determination to further expand its leadership position in the market.